$45.95
-0.26-0.56%
最終更新: Oct 9, 7:44 PM
$45.76
-0.45-0.97%
Benzinga
Benzinga
Benzinga
日曜日, 10 11
Benzinga
© 2026 Benzinga | All Rights Reserved
AnaptysBio (ANAB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.46 | $-0.66 | $0.92 | $-1.17 |
| Actual | $-0.11 | $-1.84 | $1.58 | $0.52 |
| Surprise | +76.1% | -178.8% | +71.7% | +144.4% |
| Revenue | ||||
| Estimate | $21.7M | $18.9M | $86.0M | $25.6M |
| Actual | $27.5M | $25.6M | $108.2M | $76.3M |
| Surprise | +26.8% | +35.4% | +25.9% | +198.7% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.72 | $1.34 | $0.85 | $0.95 |
| Revenue | ||||
| Consensus | $33.2M | $49.0M | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Sep 21, 2026 | $-0.11 | $-0.46 | 76.1 % |
| Q1 | May 12, 2026 | $-1.84 | $-0.66 | -178.8 % |
| Q4 | Mar 3, 2026 | $1.58 | $0.92 | 71.7 % |
| Q3 | Nov 4, 2025 | $0.52 | $-1.17 | 144.4 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Sep 21, 2026 | $27.49M | $21.68M | 26.8 % |
| Q1 | May 12, 2026 | $25.56M | $18.87M | 35.4 % |
| Q4 | Mar 3, 2026 | $108.24M | $85.96M | 25.9 % |
| Q3 | Nov 4, 2025 | $76.32M | $25.55M | 198.7 % |